# BioVersys AG (BIOV.SW): MoatMap facts

As of 13 Nov 2026. Research data, not investment advice.

As of 13 Nov 2026, the MoatMap Score for BioVersys AG (BIOV.SW) is 13/100, ranked against 25,000+ stocks in 38 markets (Quality 28, Value 26, Momentum 35, each scored against its sector).

- MoatMap Score: 13/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 28, Value 26, Momentum 35: each a 0-100 percentile within Healthcare.
- Position: #23,246 overall, #2,151 in Healthcare.
- Listing: Switzerland, EBS; Healthcare / Biotechnology.
- Last close: 23.9 CHF on 12 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/BIOV.SW
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker